Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 683 of 767

Advanced search

🌍Jun 6Industryorthofix.comTier 1 · Company source

Staged L4–L5 Anterior to Psoas (ATP) Approach with Posterior Instrumentation

OrthofixOriginal source

🇺🇸Jun 5Industryinvestors.amneal.comTier 1 · Company source

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

Amneal Pharmaceuticals RSSOriginal source

🇺🇸Jun 5Researchmdanderson.orgTier 2 · Direct publisher

Life with astrocytoma: Young brain tumor survivor shares her cancer story

MD Anderson Cancer CenterOriginal source

🌍Jun 5Researchpnas.orgTier 2 · Direct publisher

When bird flu jumped to cows, just 10 viral particles were enough to cause infection

PNASOriginal source

🌍Jun 5Mediavalneva.comTier 2 · Direct publisher

Making Sustainability Durable: Why Governance Matters in Healthcare

ValnevaOriginal source

🇯🇵Jun 4Researchriken.jpTier 2 · Direct publisher

Message from President Gonokami regarding the new Japan-US strategic partnership on “AI for Science”

RIKENOriginal source

🇺🇸Jun 4CROmedidata.comTier 2 · Direct publisher

Mastering the Complexity: A Pragmatic Approach to AI in Clinical Data Management

Medidata SolutionsOriginal source

🇺🇸Jun 4CDMOinvestors.emergentbiosolutions.comTier 2 · Direct publisher

Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose

Emergent BioSolutionsOriginal source

🇯🇵Jun 4pharma_equipmentprodcms.ulvac.co.jpTier 2 · Direct publisher

ULVAC Group Receives Three Awards Including the Grand Prize at the 2025 JVIA Awards

Ulvac (Pharma)Original source

🌍Jun 4Industryrss.globenewswire.comTier 3 · Secondary coverage

Drew Brees Collaborates with ARS Pharmaceuticals to Raise Awareness About Living Life with Severe Allergies

ARS PharmaceuticalsOriginal source

🌍Jun 4Industryrss.globenewswire.comTier 3 · Secondary coverage

GH Research Announces Publication of Phase 2a Postpartum Depression Results

GH ResearchOriginal source

🇺🇸Jun 4Industryfatetherapeutics.comTier 1 · Company source

FT839: A Multi-Antigen Targeting Off-the-Shelf Dual-CAR T Cell for the Treatment of Pathogenic B and T Cells in Autoimmune Diseases

Fate TherapeuticsOriginal source

🇺🇸Jun 4Industryfatetherapeutics.comTier 1 · Company source

Safety and Efficacy of an Off-the-Shelf Anti-CD19 CAR T-Cell Therapy With Reduced Conditioning in SLE: A Phase 1 Study Supporting Same-Day Discharge

Fate TherapeuticsOriginal source

🇯🇵Jun 4CROen.cmicgroup.comTier 2 · Direct publisher

CMIC HOLDINGS Reaches Agreement with SGS to Transfer All Shares of CMIC, INC.

CMIC Group JapanOriginal source

🌍Jun 4Mediaproscia.comTier 2 · Direct publisher

Intelligence for the decisions that matter most

ProsciaOriginal source

🇮🇹Jun 3Researchhumanitas-research.comTier 3 · Secondary coverage

Nanomedicine: Italian research to improve the treatment of brain tumors

Humanitas Research Hospital (Milan)Original source

🌍Jun 3Researchopenclinica.comTier 2 · Direct publisher

What Is a Unified eClinical Platform, Actually?

OpenClinicaOriginal source

🇸🇬Jun 2Regulatoryapacmed.orgTier 1 · Regulatory source

When Regulators Use AI: What It Means for MedTech Teams

APACMedOriginal source

🇺🇰Jun 2Researchphar.cam.ac.ukTier 2 · Direct publisher

Department of Pharmacology Recent Publications: February 2026 - May 2026

Cambridge Pharma ResearchOriginal source

🌍Jun 2Mediaheartsciences.comTier 2 · Direct publisher

HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm

HeartSciencesOriginal source

🌍Jun 2Industrypowerfulmedical.comTier 1 · Company source

AZORG Hospitals Cut Subtle Heart Attack Treatment Delays by Several Hours with PMcardio Platform

Powerful MedicalOriginal source

🌍Jun 2Mediasaama.comTier 2 · Direct publisher

How the Medical Writing Demand Gap Is Becoming a Drug Development Bottleneck

SaamaOriginal source

🇺🇰Jun 2Researchphar.cam.ac.ukTier 2 · Direct publisher

Announcing the Cambridge Protein Screening Facility website!

Cambridge Pharma ResearchOriginal source

🌍Jun 2Industrysubtlemedical.comTier 1 · Company source

Subtle Medical Secures $33 Million in Growth Capital Led by Morgan Stanley Expansion Capital and Appoints Industry Veteran Ohad Arazi as CEO

Subtle MedicalOriginal source

🇺🇸Jun 2Industryfatetherapeutics.comTier 1 · Company source

Preliminary Phase 1 Results of a MICA/B-targeted CAR T cell Designed to Overcome Solid Tumor Escape Mechanisms and Avoid the Requirement for Conditioning Chemotherapy

Fate TherapeuticsOriginal source

🇺🇸Jun 2Industry4gclinical.comTier 1 · Company source

No. Matter. What: Evidence That Reflects Every Patient

4G ClinicalOriginal source

🌍Jun 1Industryorthofix.comTier 1 · Company source

From Nerve Pain to Full Recovery: Jason’s CervicalStim Device Experience

OrthofixOriginal source

🇺🇸Jun 1CROir.criver.comTier 2 · Direct publisher

Charles River Laboratories to Present at William Blair and Jefferies Conferences

Charles River LaboratoriesOriginal source

🇩🇪Jun 1Researchcharite.deTier 2 · Direct publisher

Making climate-neutral plastics and cosmetics using bacteria

Charité - Universitätsmedizin Berlin (EN)Original source

🇨🇭Jun 1CDMOsiegfried.chTier 2 · Direct publisher

Change in Siegfried’s management team

SiegfriedOriginal source

🌍Jun 1Researchpnas.orgTier 2 · Direct publisher

Cyclic deformation resets a rock’s microstructural clock

PNASOriginal source

🇯🇵Jun 1Industrysumitomo-pharma.comTier 1 · Company source

Sumitomo Pharma Announces Organizational Change, Change in the Responsibilities of Executive Officer, and Personnel Change

Sumitomo PharmaOriginal source

🌍Jun 1Industrymenicon.comTier 1 · Company source

Flat Pack Packaging Now Uses Less Plastic with New Direct Printing Machine

MeniconOriginal source

🌍May 30Industrybicara.comTier 1 · Company source

ASCO 2026 Poster Presentation: A multicenter, randomized, double-blind, phase 2/3 study of ficerafusp alfa (BCA101) or placebo in combination with pembrolizumab for first-line treatment of PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: FORTIFI-HN01

Bicara TherapeuticsOriginal source

🌍May 30Industrybicara.comTier 1 · Company source

ASCO 2026 Poster Presentation: The impact of depth of response on long-term clinical outcomes: Exploratory analyses from multiple expansion cohorts of a phase 1/1b study of ficerafusp alfa plus pembrolizumab in first-line recurrent/metastatic (R/M) HPV-negative head and neck squamous cell carcinoma (HNSCC)

Bicara TherapeuticsOriginal source

🌍May 30Industrybicara.comTier 1 · Company source

ASCO 2026 Poster Presentation: Sustained depth and durability of response with TGF-β trapping in recurrent or metastatic (R/M) HPV-negative head and neck squamous cell carcinoma (HNSCC): Long-term results from expansion cohorts of a phase 1/1b study of ficerafusp alfa plus pembrolizumab

Bicara TherapeuticsOriginal source

🇸🇬May 30Researchscri.edu.sgTier 2 · Direct publisher

Clinical Research Coordinator Onboarding Programme (May 2026 Intake)

Singapore Clinical Research InstituteOriginal source

🌍May 29Industryaptose.comTier 1 · Company source

Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical

Aptose BiosciencesOriginal source

🌍May 29Regulatoryravimiamet.eeTier 1 · Regulatory source

The Estonian medicinal products market in the first quarter 2026

SAM EstoniaOriginal source

🌍May 29Mediacentogene.comTier 2 · Direct publisher

Reproductive Carrier Screening Portoflio Update

CentogeneOriginal source

🇯🇵May 29Industrysumitomo-pharma.comTier 1 · Company source

Posted Notice of Convocation of the 206th Annual Shareholders' Meeting

Sumitomo PharmaOriginal source

🇺🇸May 29CDMOinvestors.emergentbiosolutions.comTier 2 · Direct publisher

Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy

Emergent BioSolutionsOriginal source

🌍May 29Regulatorytransceleratebiopharmainc.comTier 1 · Regulatory source

Why 2026 could be a turning point for patient-focused trials

TransCelerate BioPharmaOriginal source

🌍May 29Researchopenclinica.comTier 2 · Direct publisher

Why Your Study Workflow Is Broken (And It’s Not Your Team)

OpenClinicaOriginal source

🌍May 28Regulatorymyscrs.orgTier 1 · Regulatory source

AI Governance at the Site: Practical Frameworks Sites Need Now

SCRS (Clinical Research Sites)Original source

🌍May 28Industryrelmada.comTier 1 · Company source

Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference

Relmada TherapeuticsOriginal source

🇺🇸May 28Researchmdanderson.orgTier 2 · Direct publisher

Lung cancer treatment is evolving with smarter combination therapies

MD Anderson Cancer CenterOriginal source

🇸🇪May 28CDMOrecipharm.comTier 2 · Direct publisher

Recipharm boosts BFS capacity with strategic manufacturing investment

Recipharm PressOriginal source

🇮🇹May 28Mediamg2.itTier 2 · Direct publisher

Le opercolatrici della serie E conquistano Interpack 2026

MG2 s.r.l.Original source

🇮🇹May 28Mediamg2.itTier 2 · Direct publisher

The E Series capsule fillers stand out at Interpack 2026

MG2 s.r.l.Original source

🇺🇸May 28Researchnews.emory.eduTier 2 · Direct publisher

Christopher L. Augostini named 22nd president of Emory University | Emory University | Atlanta GA

Emory University School of MedicineOriginal source

🌍May 27Industryorchestrabiomed.comTier 1 · Company source

BACKBEAT Timeline Update Reinforces Momentum to Pivotal Trial Data Presentation and Regulatory Submissions by Medtronic

Orchestra BioMedOriginal source

🇺🇸May 27Devicesapyxmedical.comTier 1 · Company source

Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway

Apyx MedicalOriginal source

🌍May 27Industryir.biolinerx.comTier 1 · Company source

BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update

BioLineRxOriginal source

🌍May 27Industrysubtlemedical.comTier 1 · Company source

Subtle Medical Receives FDA Clearance for SubtleHD™(PET), Next-Generation AI-Powered Image Acceleration and Enhancement Software

Subtle MedicalOriginal source

🇮🇹May 27Researchhumanitas-research.comTier 3 · Secondary coverage

Maternal interferon and brain development: new clues about neurodevelopment disorders

Humanitas Research Hospital (Milan)Original source

🌍May 27Industrycibeles.com.uyTier 1 · Company source

STIGMAR XTRA

Cibeles (Uruguay)Original source

🌍May 27Industrycibeles.com.uyTier 1 · Company source

Stigmar xtra

Cibeles (Uruguay)Original source

🇺🇸May 27Researchnews.emory.eduTier 2 · Direct publisher

Angela Dash to join Emory University Ombuds Office | Emory University | Atlanta GA

Emory University School of MedicineOriginal source

🇺🇸May 26CROcaidya.comTier 2 · Direct publisher

Pharmacovigilance and Safety Reporting Requirements for Clinical Trials

Caidya (Clinipace)Original source